|
KROS Keros Therapeutics Inc 1664710 |
| Balance Sheet |
|
Current Assets
|
588,893,000 |
|
Assets
|
615,886,000 |
|
Current Liabilities
|
27,450,000 |
|
Liabilities
|
44,333,000 |
|
Equity
|
571,553,000 |
|
Shares Out
|
19,718,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-160,869,000 |
|
Investing Cash Flow
|
-1,931,000 |
| Market Analysis |
Market Cap
|
225,568,534 |
|
Price
|
11.44 |
|
BVPS
|
15.23 |
|
PB
|
0.75 |
|
EPS
|
2.30 |
|
PE
|
4.98 |
|
PS
|
145.44 |
|
FCF
|
-162,800,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KROS documents filed with the SEC.
KROS Filings
Clear
